Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-05-23
1998-09-08
Sidberry, Hazel F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242341, 4242371, 4242401, 4242431, 4242531, 4242611, A61K 39108, A61K 39112, A61K 39106, A61K 39085
Patent
active
058041982
ABSTRACT:
An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
REFERENCES:
patent: 4157390 (1979-06-01), Parry et al.
patent: 4237115 (1980-12-01), Brinton, Jr.
patent: 4311797 (1982-01-01), Khachatourians
patent: 4336336 (1982-06-01), Silhavy et al.
patent: 4343792 (1982-08-01), Gouet et al.
patent: 4443431 (1984-04-01), Buchanan et al.
patent: 4454116 (1984-06-01), Brinton
patent: 4454117 (1984-06-01), Brinton
patent: 4461838 (1984-07-01), Brinton et al.
patent: 4521334 (1985-06-01), Beachey
patent: 4597967 (1986-07-01), Beachey et al.
patent: 4652448 (1987-03-01), Sadowski
patent: 4657849 (1987-04-01), Kallenius et al.
patent: 4736017 (1988-04-01), O'Hanley et al.
patent: 4786592 (1988-11-01), Deal et al.
patent: 4801690 (1989-01-01), Brinton, Jr. et al.
Arnon, R., et al., J. of Imunological Methods, vol. 61, pp. 261-273 (1983) (Exhibit 1).
Bagdasarian, M., et al., Gene, vol. 26, pp. 273-282 (1983) (Exhibit 2).
Beachey, E., J. of Infectious Diseases, vol. 143, No. 3, pp. 325-345 (1981) (Exhibit 3).
Bjork, G. and Olsen, A., Acta Chem. Scand. Ser. B33, pp. 591-593 (1979) (Exhibit 4).
Bolivar, F., et al., Gene, vol. 2, pp. 95-113 (1977) (Exhibit 5).
Brinton, C., et al., in Immunobiology of Neisseria gonorrhoeae. Washington, D.C. (1978)., pp. 155-178 (Exhibit 6).
Dallas, W., and Falkow, S., Nature, vol. 277, pp. 406-407 (1979) (Exhibit 7).
Greenfield, L., Biochimica et Biophysica Acta, vol. 407, pp. 365-375 (1975) (Exhibit 8).
Hull, R., et al., Infection and Immunity, vol. 33, No. 3, pp. 933-938 (1981) (Exhibit 9).
Messing, J., et al., Nucleic Acids Research, vol. 9, No. 2., pp. 309-321 (1981) (Exhibit 10).
Meyer, T., et al., Cell, vol. 30, pp. 45-52 (1982) (Exhibit 11).
O'Hanley, P., et al., J. Exp. Med., vol. 158, pp. 1713-1719 (1983) (Exhibit 12).
Shinnick, T., et al., Ann. Rev. Microbiol., vol. 37, pp. 425-446 (1983) (Exhibit 13).
van Die, I., et al., FEMS Microbiology Letters, vol. 19, pp. 77-82 (1983) (Exhibit 14).
Eden, C., et al., Prog. Allergy, vol. 33, pp. 189-202 (1983) (Exhibit 43).
Dougan, G., et al., J. of Bacteriology, vol. 153, pp. 364-370 (1983). (Exhibit 44).
Gaastra, W. and de Graaf, F., Microbiological Reviews, vol. 46, No. 2, pp. 129-161 (1982) (Exhibit 45).
Hull, R., et al., Infection and Immunity, vol. 43, pp. 1064-1067 (1984) (Exhibit 46).
Klemm, P., Eur. J. Biochemistry, vol. 143, pp. 395-399 (1984) (Exhibit 47).
Mooi, F., et al., J. of Bacteriology, vol. 159, No. 2, pp. 482-487 (1984) (Exhibit 48).
Mooi, F., et al., J. of Bacteriology, vol. 150, No. 2, pp. 512-521 (1982) (Exhibit 49).
Norgren, M., et al, EMBP Journal., vol. 3, No. 5, pp. 1159-1165 (1984) (Exhibit 50).
Orskov, I. and Orskov, F., Prog. Allergy, vol. 33, pp. 80-105 (1983) (Exhibit 51).
van Die, I., et al., Mol. Gen. Genet., vol. 194, pp. 528-533 (1984) (Exhibit 52).
Worobec, E., et al., J. of Bacteriology, vol. 153, No. 2, pp. 955-961 (1983) (Exhibit 53).
Leffler et al Inf Imm 34: 920-929 1981.
Hull et al, Infect. Immun., 43, 1064-1067, 1984.
Adler, et al.; Miniature Escherichia Coli Cells Deficient in DNA; PNAS; 57:321-26 (1967).
Thompson, et al.; The Control Region of the F Sex Factor DNA Transfer Cistrons:Restriction Mapping and DNA Cloning; Molec. Gen Genet.; 165:295-304 (1978).
Grundstrom, et al.; Physical Mapping and Expression of Hybrid Plasmids Carrying Chromosomal beta-Lactamase Genes of Escherichia coli K-12; J. Bacteriol.; 143(3):1127-34 (1980).
Swanson, et al.; Antigenicity of Neisseria Gonorrhoeae Outer Membrane Protein(s) III Detected by Immuno-precipitation and Western Blot Transfer . . . ; Infection and Immunity; 38(2):668-72 (1982).
Mandel, et al.; Calcium-dependent Bacteriophage DNA Infection; J. Mol. Biol.; 53:159-62 (1970).
Birnbolm, et al.; A Rapid Alkaline Extraction Procedure for Screening Recombinant Plasmid DNA; Nucleic Acid Research; 7(6):1513-23 (1979).
Collins; Escherichia coli Plasmids Packageable in Vitro in Lambda Bacteriophage Particles; Methods Enzymol. 68:309-326 (1979).
Baga, et al.; Nucleotide Sequence of the papA Gene Encoding the Pap Pilus Subunit of Human Uropathogenic Escherichia Coli; J. Bacteriol.; 157(1):330-333 (1984).
Normark, et al.; Genetics of Digalactoside-Binding Adhesin from a Uropathogenic Escherichia coli Strain; Infection and Immunity; 41(3):942-949 (1983).
Sanger, et al.; DNA Sequencing with Chain-Terminating Inhibitors; PNAS; 74(12):5463-67 (1977).
VonHeijne; Patterns of Amino Acids Near Signal-Sequence Cleavage Sites; Eur. J. Biochem.; 133:17-21 (1983).
Clegg, et al.; Organization of Genes Responsible for the Production of Mannose-Resistant Fimbriae of a Uropathogenic Escherichia coli Isolate; Infection & Immunity; 42(3):900-06 (1983).
Low, et al.; Gene Clusters Governing the Production of Hemolysin and Mannose-Resistant Hemagglutination Are Closely Linked . . . Infections; Infection & Immunity; 43(1):353-358 (1984).
Casadaban, et al.; In Vitro Gene Fusions that Join an Enzymatically Active beta-Galactosidase Segment to Amino-Terminal . . . Signals; J. Bacteriol.; 143(2):971-980 (1980).
Bertani, G.; Studies on Lysogenesis; J. Bacteriol.; 62:293-300 (1951).
Uhlin, et al.; New Runaway-Replication-Plasmid Cloning Vectors and Suppression of Runaway Replication By Novobiocin; Gene; 22:255-265 (1983).
Beachey et al Journ. of Inf. Dis. vol. 143 325-345 1981.
Pecha et al, The Journ. of Clinical Invest 83: 2102-2108 1989.
Denich et al Inf & Immun. 59: 3849-3858, 1991.
O'Hanley J. Clin Invest 75: 347-360, 1985.
Tramont et al The Pathogenic Neisseria 1985 pp. 316-323.
Jones et al, Infect & Immun. 60:4440-4451 1992.
Lund et al J of Bact 170:1887-1894, 1988.
Schmidt et al J. of Exp Med 161:705-707, 1984.
Bosleyo et al; Vaccine 9:154-162, 1991 Efficacy Trial of a Parenteral Gonococcal pitus vaccine in men.
O'Hanley, New Generation Vaccines, Chapter 37, pp. 631-665, 1990.
Boslego et al, Vaccines and Immunotherapy, Chapter 17, pp. 211-224, 1991.
Czyz, Vaccines and Immunotherapy, Chapter 12, pp. 156-165, 1991.
B.ang.ga Britt Monika
Goransson Mikael
Lark David Lee
Lindberg Frederik Carl
Lund Bjorn Olof
Cooer Iver P.
Sidberry Hazel F.
Symbicom Aktiebolag
LandOfFree
Vaccines against disease caused by pathogenic pilus-forming bact does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines against disease caused by pathogenic pilus-forming bact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines against disease caused by pathogenic pilus-forming bact will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279665